BCRX
Companies
NASDAQ
BioCryst Pharmaceuticals Inc.
Health Care
$9.96
+$2.44 (+32.45%)
Price Chart
Overview
About BCRX
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Market Cap
$1.3B
Volume
26.0M
Avg. Volume
35.7M
P/E Ratio
-166.5
Dividend Yield
0.00%
Employees
513.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.96
Moderate Correlation
Volatility
High (0.56)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, BCRX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.3B
Volume26.0M
P/E Ratio-166.50
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 24, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025